Relating to access to certain investigational drugs, biological products, and devices used in clinical trials by patients with severe chronic diseases.
Relating to access to certain investigational drugs, biological products, and devices used in clinical trials by patients with severe chronic diseases.
Relating to the right to try cutting-edge treatments for patients with life-threatening or severely debilitating illnesses.
Relating to the right to try cutting-edge treatments for patients with life-threatening or severely debilitating illnesses.
Relating to the right to try cutting-edge treatments for patients with life-threatening or severely debilitating illnesses.
Relating to the prescriptive authority of certain psychologists; authorizing a fee.
Relating to authorizing the possession, use, cultivation, distribution, delivery, sale, and research of medical cannabis for medical use by patients with certain medical conditions and the licensing of medical cannabis organizations; authorizing fees.
Relating to the disclosure by a pharmacy to a patient of certain price information for a drug or biological product.
Relating to the terminology used in statute to refer to intellectual disability and certain references to abolished health and human services agencies.
Relating to the terminology used in statute to refer to intellectual disability and certain references to abolished health and human services agencies.